Public annual accounts

DR. PETER GEELEN financials

Name: DR. PETER GEELEN financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for DR. PETER GEELEN, with comparable measures and links to available source documents.

Company overview

Registry number

0864297813

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

Latest movements for DR. PETER GEELEN

2025 versus 2024

Operating line: €375,500
EBITDA: €373,631
Total assets: €1,701,434
Equity: €1,656,461

EBITDA margin +99.5% · Equity ratio +97.4%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€375,500	€373,631	€1,701,434	€1,656,461	-
202431 Dec 2024	€352,809	€338,760	€1,700,878	€1,602,431	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report